Abstract
Gelatin has been used in hard capsule shells for more than a century, and some shortcomings have appeared, such as high moisture content and risk of transmitting diseases of animal origin to people. Based on available studies regarding gelatin and vegetable shells, we developed a new type of algal polysaccharide capsule (APPC) shells. To test whether our products can replace commercial gelatin shells, we measured in-vivo plasma concentration of 12 selected volunteers with a model drug, ibuprofen, using high performance liquid chromatography (HPLC), by calculating the relative bioavailability of APPC and Qualicaps® referenced to gelatin capsules and assessing bioequivalence of the three types of shells, and calculated pharmacokinetic parameters with the software DAS 2.0 (China). The results show that APPC shells possess bioequivalence with Qualicaps® and gelatin shells. Moreover, the disintegration behavior of four types of shells (APPC, Vegcaps®, Qualicaps® and gelatin shells) with the content of lactose and radioactive element (99mTc) was observed via gamma-scintigraphic images. The bioavailability and gamma-scintigraphic studies showed that APPC was not statistically different from other vegetable and gelatin capsule shells with respect to in-vivo behavior. Hence, it can be concluded that APPCs are exchangeable with other vegetable and gelatin shells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Brown J, Madit N, Cole E T, Wilding I R, Cade D. 1998. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules. Pharm. Res., 15(7): 1 026–1 030.
Chiwele I, Jones B E, Podczeck F. 2000. The shell dissolution of various empty hard capsules. Chem. Pharm. Bull., 48(7): 951–956.
Cole E T, Scott R A, Cade D, Connor A L, Wilding I R. 2004. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules. Pharm. Res., 21(5): 793–798.
Desai D S, Rubitski B A, Bergum J S, Varia S A. 1994. Effects of different types of lactose and disintegrant on dissolution stability of hydropchlorothiazide capsule formulations. Int. J. Pharm., 110(3): 257–265.
Digenis G A, Gold T B, Shah V P. 1994. Cross-linking of Gelatin capsules and its relevance to their in-vitro in vivo perfomance. J. Pharm. Sci., 83(7): 915–921.
El-Malah Y, Nazzal S, Bottom C B. 2007. Hard gelatin and hypromellose (HPMC) capsules: Estimation of rupture time by real-time dissolution spectroscopy. Drug Dev. Ind. Pharm., 33(1): 27–34.
Hakata T, Sato H, Watanabe Y, Matsumoto M. 1994. Effect of storage-temperature on the physicochemical properties of soft gelatin capsule shell. 6. Studies on soft gelatin capsules. Chem. Pharm. Bull., 42(7): 1 496–1 500.
Honkanen O, Marvola J, Kanerva H, Lindevall K, Lipponen M, Kekki T, Ahonen A, Marvola M. 2004. Gamma scintigraphic evaluation of the fate of hydroxypropyl methylcellulose capsules in the human gastrointestinal tract. Eur. J. Pharm. Sci., 21(5): 671–678.
Honkanen O, Pia L, Janne M, Sari E, Raimo T, Martti M. 2002. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations. Eur. J. Pharm. Sci., 15(5): 479–488.
Marvola J, Kanerva H, Slot L, Lipponen M, Kekki T, Hietanen H, Mykkanen S, Ariniemi K, Lindevall K, Marvola M. 2004. Neutron activation-based gamma scintigraphy in pharmacoscintigraphic evaluation of an Egalet (R) constant-release drug delivery system. Int. J. Pharm., 281(1–2): 3–10.
Marvola T, Marvola J, Kanerva H, Ahonen A, Lindevall K, Marvola M. 2008. Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon. Int. J. Pharm., 349(1–2): 24–29.
Misale B V, Gavali H B M, Katare S D, Yadav A V. 2008. Sago starch capsule shell: A suitable alternative to gelatin capsule shells. Indian J. Pharm. Educ. Res., 42(1): 48–52.
Nagata S. 2001. Cellulose capsules—analternative to gelantin: structural, functional and community aspects. In: Chiellini E, Sunamoto J, Migliaresi C eds. Biomedical Polymers and Polymer Therapeutics. New York: Kluwer Academic. p.53–62.
Newman S P, Hirst P H, Wilding I R. 2003. New developments in radionuclide imaging for assessing drug delivery in man. Eur. J. Pharm. Sci., 18(1): 19–22.
Ofner C M, Zhang Y E, Jobeck V C, Bowman B J. 2001. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity. J. Pharm. Sci., 90(1): 79–88.
Sakata Y, Otsuka M. 2009. Evaluation of relationship between molecular behaviour and mechanical strength of pullulan films. Int. J. Pharm., 374(1–2): 33–38.
Tuleu C, Khela M K, Evans D F, Jones B E, Nagata S, Basit A W. 2007. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: A comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules. Eur. J. Pharm. Sci., 30(3–4): 251–255.
Vilivalam V D, Illum L, Iqbal K. 2000. Starch capsules: An alternative system for oral drug delivery. Pharm. Sci. Tech. Today, 3(2): 64–69.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National High Technology Research and Development Program of China (863 program) (No. 2007AA091604) and the Knowledge Innovation Project of Chinese Academy of Sciences (No. KZCX2-YW-209)
Rights and permissions
About this article
Cite this article
Li, T., Guo, S., Ma, L. et al. Effects of alga polysaccharide capsule shells on in-vivo bioavailability and disintegration. Chin. J. Ocean. Limnol. 30, 22–28 (2012). https://doi.org/10.1007/s00343-012-1011-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00343-012-1011-4